Table 1. Patient demographic and clinical characteristics.
| Characteristics | Data |
|---|---|
| Age (years) | 17–70 (41.74±14.58) |
| Sex | |
| Female | 21 (36.21%) |
| Male | 37 (63.79%) |
| 2016 World Health Organization grade | |
| II | 33 (56.90%) |
| Diffuse astrocytoma | IDH1 wild-type 13 (39.39%) |
| IDH1 mutation 6 (18.18%) | |
| Oligodendroglioma | IDH1 mutation 13 (39.39%) |
| Astrocytoma | IDH1 wild-type 1 (3.03%) |
| III | 13 (22.41%) |
| Anaplastic astrocytoma | IDH1 wild-type 11 (84.62%) |
| IDH1 mutation 2 (15.38%) | |
| IV | 12 (20.69%) |
| Glioblastoma | IDH1 wild-type 11 (91.67%) |
| Diffuse midline glioma | IDH1 wild-type 1 (8.33%) |
| Tumor location | |
| Frontal lobe | 28 (48.28%) |
| Temporal lobe | 7 (12.07%) |
| Parietal lobe | 2 (3.45%) |
| Occipital lobe | 0 (0.00%) |
| Multiple lobes | 6 (10.34%) |
| Cerebellum | 2 (3.45%) |
| Deep brain regions | 13 (22.41%) |
| Surgical treatment | |
| Resection | 39 (81.03%) |
| Total resection | 20 (51.28%) |
| Partial resection | 19 (49.72%) |
| Stereotactic biopsy | 19 (18.97%) |
| IDH1 status | |
| Wild type | 37 (63.79%) |
| Mutation | 21 (36.21%) |
Range, mean, and standard deviation of age are provided. Other dichotomous and categorical items are shown as percentages. IDH1, isocitrate dehydrogenase gene 1.